RBC Capital Maintains Outperform on HealthEquity, Lowers Price Target to $70
RBC Capital analyst Sean Dodge maintains HealthEquity (NASDAQ:HQY) with a Outperform and lowers the price target from $87 to $70.
Recap: HealthEquity Q3 Earnings
HealthEquity (NASDAQ:HQY) reported its Q3 earnings results on Monday, December 6, 2021 at 04:02 PM.
Here's what investors need to know about the announcement.
HealthEquity Q3 Adj. EPS $0.35, Inline, Sales $180.00M Miss $185.05M Estimate
HealthEquity (NASDAQ:HQY) reported quarterly earnings of $0.35 per share which met the analyst consensus estimate. This is a 14.63 percent decrease over earnings of $0.41 per share from the same period last year. The
5 Stocks To Watch For December 6, 2021
Some of the stocks that may grab investor focus today are:
Earnings Scheduled For December 6, 2021
Companies Reporting Before The Bell
• DLH Hldgs (NASDAQ:DLHC) is projected to report quarterly earnings at $0.22 per share on revenue of $63.00 million.
Jefferies Initiates Coverage On HealthEquity with Buy Rating, Announces Price Target of $68
Jefferies analyst Glen Santangelo initiates coverage on HealthEquity (NASDAQ:HQY) with a Buy rating and announces Price Target of $68.